0001209191-21-022928.txt : 20210324 0001209191-21-022928.hdr.sgml : 20210324 20210324181823 ACCESSION NUMBER: 0001209191-21-022928 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20210324 DATE AS OF CHANGE: 20210324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARDINER SANDRA A. CENTRAL INDEX KEY: 0001218574 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 21769457 MAIL ADDRESS: STREET 1: CUTERA, INC. STREET 2: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER NAME: FORMER CONFORMED NAME: GARDINER SANDRA DATE OF NAME CHANGE: 20030212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-09 0 0001625101 Pulse Biosciences, Inc. PLSE 0001218574 GARDINER SANDRA A. 3957 POINT EDEN WAY HAYWARD CA 94545 0 1 0 0 CFO & EVP Admin. and Finance Stock Option (right to buy) 13.94 2020-12-09 4 A 0 25961 0.00 A 2029-11-18 Common Stock 25961 25961 D Stock Option (right to buy) 10.66 2021-02-23 4 A 0 8750 0.00 A 2030-05-18 Common Stock 8750 8750 D Stock Option (right to buy) 24.03 2021-03-22 4 A 0 18000 0.00 A 2022-03-01 2031-03-22 Common Stock 18000 18000 D Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met with respect to performance-based stock options granted to the Reporting Person on November 18, 2019. Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date. /s/ Sandra Gardiner 2021-03-24